drugset / Trial / NCT03326596

Prevention of Postpartum Hemorrhage With TXA

NCT03326596 ↗

NaSingle-groupOpen-labelPrevention

Summary

Hemorrhage remains the leading cause of maternal death worldwide. Tranexamic acid has been shown to reduce rates of hemorrhage when given prophylactically prior to cesarean delivery. It has also been shown to be an effective treatment in response to hemorrhage after a vaginal delivery. The aim of this study is to assess the impact of TXA on hemorrhage rates when given prophylactically prior to all deliveries.

Timeline

Start
2018-04-20
Primary completion
2019-06
Completion
2019-09

Outcome

Outcome not reported

Stopped: “PI retired from Navy 2018”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1000 mg Intravenous

Indications

No indication recorded.